Clinical review
Sulfur mustard: Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy

https://doi.org/10.1016/0190-9622(95)91457-9Get rights and content

Abstract

Although sulfur mustard (SM) has been used as a chemical warfare agent since the early twentieth century, it has reemerged in the past decade as a major threat around the world. SM is an agent that is easily produced even in underdeveloped countries and for which there is no effective therapy. This agent is a potential threat not only on the battlefield but also to civilian populations. The skin and other epithelial surfaces are the first targets as this agent is absorbed, and reactions within the skin are the subject of active research into the mechanism of action of this alkylating agent. The depletion of glutathione, generation of reactive oxygen species, and the formation of stable DNA adducts remain theoretic and demonstrated by-products of SM exposure implicated in the disease produced. However, new findings related to the effects of SM on the basement membrane zone; interest in delayed healing of the lesions induced; the inflammatory mediators, enzymes, and cytokines that result; and cellular typing of the inflammatory infiltrate will increase our understanding of the pathophysiology of the lesions caused by SM. In addition, the recent development of a topical skin protectant for SM and for other chemical warfare agents may have broad applications within dermatology.

References (79)

  • MAE Mol et al.

    NAD+ levels and glucose uptake of cultured human epidermal cells exposed to sulfur mustard

    Toxicol Appl Pharmacol

    (1989)
  • MAE Mol et al.

    Effects of nicotinamide on biochemical and morphological changes induced by sulfur mustard in human skin organ culture

    Toxicol Appl Pharmacol

    (1991)
  • JJ Yourick et al.

    Niacinamide pretreatment reduces microvesicle formation in hairless guinea pigs cutaneously exposed to sulfur mustard

    Fundam Appl Toxicol

    (1991)
  • TM Buttke et al.

    Oxidative stress as a mediator of apoptosis

    Immunol Today

    (1994)
  • S Miccadei et al.

    Toxic consequence of the abrupt depletion of glutathione in cultured rat hepatocytes

    Arch Biochem Biophys

    (1988)
  • CW Trenam et al.

    Skin inflammation: reactive oxygen species and the role of iron

    J Invest Dermatol

    (1992)
  • G Opdenakker et al.

    Cytokine-regulated proteases in autoimmune disease

    Immunol Today

    (1994)
  • Y Miyachi et al.

    Decreased skin superoxide dismutase activity by a single exposure of ultraviolet radiation is reduced by liposomal superoxide dismutase pretreatment

    J Invest Dermatol

    (1987)
  • AB Wysocki et al.

    Wound fluid from chronic leg ulcers contains elevated levels of metallo-proteinase MMP-2 and MMP-9

    J Invest Dermatol

    (1993)
  • V Del Marmol et al.

    Glutathione depletion increases tyrosinase activity in human melanoma cells

    J Invest Dermatol

    (1993)
  • BA Gilchrest et al.

    Treatment of human melanocytes and S91 melanoma cells with DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation

    J Invest Dermatol

    (1993)
  • EC Vonderheid et al.

    Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

    J Am Acad Dermatol

    (1989)
  • B Papirmeister et al.

    Medical defense against mustard gas: toxic mechanisms and pharmacological implications

    (1991)
  • J Medema

    Mustard gas: the science of H. Nucl Biol Chem Def Technol Int

    (1986)
  • FE Adair et al.

    Experimental and clinical studies on the treatment of cancer by dichloroethylsulphide

    Ann Surg

    (1931)
  • L Illig et al.

    The treatment of psoriasis vulgaris with S-mustard-Vaseline externally, taking especially into consideration the possible carcinogenic risk

    Z Hautkr

    (1979)
  • WJ Smith et al.

    Medical defense against blistering chemical warfare agents

    Arch Dermatol

    (1991)
  • Project Coordination Staff

    Technical aspects of chemical warfare in the field: part 1

    (1946)
  • BP McNamara et al.

    Toxicological basis for controlling levels of mustard in the environment

    (1975)
  • DC Sinclair

    The clinical reaction of the skin to mustard gas vapor

    Br J Dermatol Syph

    (1949)
  • US Army et al.

    Disposition of personnel with vesicant (blister agent) burns: section I—general

  • US Army et al.

    Disposition of personnel with blister agent (vesicant) burns

  • B Renshaw

    Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustands

  • EK Marsheall et al.

    On dichlorethylsulphide (mustard gas). II. Variations in susceptibility of the skin to dichlorethylsulphide

    J Pharmacol Exp Ther

    (1918)
  • SM Nagy et al.

    The penetration of vesicant vapors into human skin

    J Gen Physiol

    (1946)
  • HI Maibach et al.

    Regional variation in percutaneous penetration in man

    Arch Environ Health

    (1971)
  • RH Guy et al.

    Correction factors for determining body exposure from forearm percutaneous absorption data

    J Appl Toxicol

    (1984)
  • JL Willems

    Clinical management of mustard gas casualties

    Ann Med Milit Belg

    (1989)
  • H Buscher

    Green and yellow cross

    (1944)
  • Cited by (0)

    The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army, the Department of the Navy, or the Department of Defense.

    View full text